Paternal exposure to ribavirin: pregnancy and neonatal outcome.
We report seven cases of newborns conceived within 6 months from the end or during paternal ribavirin exposure.
De Santis
Marco
M
Department of Obstetrics and Gynaecology, Telefono Rosso--Teratology Information Service, Catholic University of the Sacred Heart, Largo A Gemelli, 8. 00168 Rome, Italy. marcodesantis@rm.unicatt.it
Carducci
Brigida
B
Cavaliere
Anna Franca
AF
De Santis
Lidia
L
Lucchese
Angela
A
Straface
Gianluca
G
Caruso
Alessandro
A
D000014:Abnormalities, Drug-Induced; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005333:Fetus / Q000187:drug effects; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D018812:Paternal Exposure; D011247:Pregnancy; D011256:Pregnancy Outcome; D012254:Ribavirin / Q000009:adverse effects*
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons